Business Snapshot The company is commercializing a treatment for amblyopia (lazy eye) based on a game platform developed in partnership with UBISOFT
Target Market Amblyopia treatment
Intellectual Property Issued US and European patents
Founders Joseph Koziak, Robert Derricotte
Business Snapshot The company manufactures microfluidic platforms for the diagnostics and biomedical research markets. The technology increases the standardization, precision and reproducibility of cell assays and can be integrated with sensors and electronic devices in order to acquire, store and manage data at a single cell level.
Target Markets Diagnostics and biomedical research markets
Business Snapshot Using a unique drug discovery platform to identify and develop novel inhibitors for treatment of various inflammation diseases, such as multiple sclerosis. This platform includes several in-vitro and in-vivo models for efficient drug screening and confirmation of potential lead candidates.
Target Markets Inflammation (neuro-inflammation in particular)
Business Snapshot Developing a drug that is an alternative to testosterone replacement therapy. The drug stimulates the body's own production of testosterone rather than using synthetic hormones and steroids.
Target Markets Testosterone market (men's health)
Intellectual Property In prosecution in the United States, Europe, India, and Australia.
Business Snapshot Company possesses technology that addresses the problem of dental implant infections and failure, using innovative and proprietary inorganic crystalline hydrogels.
Target Markets Dental and implants.
Intellectual Property Patents pending in Canada, US, Europe.
Founders Faleh Marino Tamimi, Ashwaq Al-Hashedi
Business Snapshot Kanyr has proprietary data on their mechanism of action and a proprietary small molecule lead compound inhibitor allowing for the targeting of phosphatases of regenerating liver (PRLs) through a newly identified co-oncogenic partner.
Target Markets Immunotherapy (cancer).
Intellectual Property In prosecution in Canada, US, Europe, Japan, China.
Business Snapshot Company has developed a clinical stage, orally-active drug candidate with the potential to modulate the immuno-inflammatory response in cystic fibrosis patients.
Target Markets Cystic fibrosis
Intellectual Property Patents around the world
Founder Danuta Radzioch, Radu Pislariu
Business Snapshot Develop and market develop novel gene-delivering medical devices that improve human health.
Target Markets Gene-delivering coronary stent, gene-delivering film-dressing to promote and accelerate wound healing (e.g. for diabetic foot ulcers), gene-delivering sutures and gene-delivering creams to prevent scar tissue formation.
Business Snapshot Mimetogen Pharmaceuticals is a clinical stage biotechnology company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases.
Target Markets Dry eye
Intellectual Property Patents around the world
Founder Uri Saragovi
Business Snapshot Two user-focused platforms, FORECASTER and VIRTUAL CHEMIST, are used for drug discovery, metabolism prediction, combinatorial chemistry, and asymmetric catalyst design.
Target Markets Pharmaceutical companies with drug discovery capabilities and fine chemical manufacturers.
Intellectual Property Proprietary software is copyrighted.
Business Snapshot Develop a polymeric nano-delivery vehicle for therapeutics like small interfering RNA (siRNA), pDNA (plasmid DNA), shRNA (short hairpin RNA), antisense oligonucleotides (ASOs), chemotherapeutic drugs and small molecules. The delivery vehicle developed (NORAfecta) is a platform technology that can cater its suitability towards different applications, such as targeting cancer and neurodegenerative diseases.
Business Snapshot The company manufactures a low temperature plasma device for biomedical applications. For cancer applications, the technology will kill cancer cells while avoiding the surrounding healthy tissue.
Target Markets Oncology, specifically breast cancer.
Intellectual Property Granted patents in the US and Canada
Founders Valérie Léveillé
Business Snapshot The company is leveraging nanotechnology to develop smart, programmable reagents that address longstanding challenges in multiplexed protein quantification.
Target Markets Research and pharmaceutical.
Intellectual Property Patent application in the US, PCT patent application
Founders Milad Dagher, David Juncker
Business Snapshot The company manufactures high performance semiconductor sensors, frequency and timing devices. In addition, it has incorporated its pressure sensor in a wireless tissue monitoring device to address the Acute Compartment Syndrome, (ACS). ACS is a major limb-threatening muscle complication that can develop after a fracture or trauma.